Dyfyniad APA

Morgan, E., Symons, S., Heyn, C., Carrera, P., Keith, J., Mainprize, T., . . . Perry, J. (2015). NIMG-51 T1-HYPERINTENSE LESIONS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ON BEVACIZUMAB. Neuro Oncol.

Dyfyniad Arddull Chicago

Morgan, Erin, et al. "NIMG-51 T1-HYPERINTENSE LESIONS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ON BEVACIZUMAB." Neuro Oncol 2015.

Dyfyniad MLA

Morgan, Erin, et al. "NIMG-51 T1-HYPERINTENSE LESIONS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ON BEVACIZUMAB." Neuro Oncol 2015.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.